Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ADI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MARK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYTH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100379224 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SMCR8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPHB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IPO7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF13A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XIST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGFR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM186A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JRKL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on